Article
Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study
21 Nov 2024
Abstract excerpt
BACKGROUND: The role of IL-6 responses in human tuberculosis risk is unknown. IL-6 signalling inhibitors, such as tocilizumab, are thought to increase the risk of progression to tuberculosis, and screening for latent Mycobacterium tuberculosis infection before using these drugs is widely recommended. We used single nucleotide polymorphisms (SNPs) in and near the IL-6 receptor gene (IL6R), including the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
